Clatterbridge Cancer Centre

Metropolitan Borough of Wirral CH63 4JY

4 studies enrolling now · 8 studies all time

What they study most

Advanced or Inoperable Gastric Cancer, B Cell Lymphoma, Chronic Lymphocytic Leukemia, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma, Head and Neck Cancer, Mantle Cell Lymphoma, Metastatic Gastric Adenocarcinoma, Prostate Cancer, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma, Small Lymphocytic Lymphoma

Studies at this site

• A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — Recruiting now
• A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) — Recruiting now
• A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL) — Recruiting now
• International Registry for Men With Advanced Prostate Cancer (IRONMAN) — Recruiting now
• A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy — Running, not enrolling
• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) — Stopped early
• Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma — Running, not enrolling
• Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer — Completed